Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma.
about
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancerMesothelin targeted cancer immunotherapyEmerging therapeutic biomarkers in endometrial cancerPractical issues in the diagnosis of serous carcinoma of the endometriumTargeted immune therapy of ovarian cancerThe human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.Immunity and immune suppression in human ovarian cancer.A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cellsPhase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer.Early detection biomarkers for ovarian cancer.Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptorThe role of mesothelin in tumor progression and targeted therapy.Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicineMesothelin expression is a prognostic factor in cholangiocellular carcinoma.HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.Insights into endometrial serous carcinogenesis and progression.Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.Endometrial carcinoma: molecular alterations involved in tumor development and progression.Mesothelin promotes invasion and metastasis in breast cancer cells.PPP2R1A mutations are common in the serous type of endometrial cancer.FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.In vitro and in vivo activity of IMGN853, an Antibody-Drug Conjugate targeting Folate Receptor Alpha linked to DM4, in biologically aggressive endometrial cancers.Folic Acid Modulates DMBA/TPA-Induced Changes in Skin of Mice: A Study Relevant to Carcinogenesis.Folic Acid-Conjugated Cellulose Nanocrystals Show High Folate-Receptor Binding Affinity and Uptake by KB and Breast Cancer Cells
P2860
Q24622837-D09DA327-1D78-4E26-BB00-270A2B82B38AQ24656242-11B59583-A28C-4BE0-99D5-4BA0967A7C9DQ26865904-B51136A9-1D01-43A3-9032-68BE6D7BEEF8Q28072095-D673B916-E7CF-4FCE-AE7C-2A916331CD95Q28082828-B8FDA6EE-86AA-4FE4-8676-6D69BEA55FEEQ34103645-2193D353-532D-4E44-BC3B-BBA81C2FE439Q35138135-28518236-CD24-46D5-8C32-F1CEEF6936F4Q35323396-905E145B-7C5D-4FCA-BFD5-0787D36AAF60Q36508941-5AFB2D69-A377-468C-AAE3-7AA3FBECA854Q36520143-E00CDDED-BA79-49E2-AD14-95D03FCA3713Q36557169-2B07E65C-2C2A-4970-B539-00427241B0A7Q36597831-1A0336A5-9C94-4CDA-A3BF-E8B71E2DA6ADQ37014465-DE96FAF7-4AC7-4C40-9D91-DA1FC83AE28AQ37044754-E644E42C-A431-4084-BA94-C749B7F4A44FQ37069841-7D9FA7BA-8E10-4793-A0DE-C57C013A28EBQ37127024-384977CB-7F00-4E76-8951-E6400C741931Q37716642-D0ED6897-5043-498E-9A55-67294755AEB6Q37994980-2D620392-558A-4072-9B26-2052D12370AAQ39210075-5CDA4748-6B87-46DC-B57F-D50152EDD822Q39481202-409FEB41-B3F0-46D3-BA45-0C83BAED020CQ49869601-4AC57110-1FCC-4603-967C-89109F9E4F6CQ50027073-0DAC204F-0227-446F-BC8B-C7E9D9870F86Q52770196-AB069479-6DB6-40B6-B2FC-5CB0A418CF64Q58580966-7CC9C27E-97FD-4D7A-9A1C-BE0733E16ABD
P2860
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Overexpression of folate bindi ...... with uterine serous carcinoma.
@ast
Overexpression of folate bindi ...... with uterine serous carcinoma.
@en
Overexpression of folate bindi ...... with uterine serous carcinoma.
@nl
type
label
Overexpression of folate bindi ...... with uterine serous carcinoma.
@ast
Overexpression of folate bindi ...... with uterine serous carcinoma.
@en
Overexpression of folate bindi ...... with uterine serous carcinoma.
@nl
prefLabel
Overexpression of folate bindi ...... with uterine serous carcinoma.
@ast
Overexpression of folate bindi ...... with uterine serous carcinoma.
@en
Overexpression of folate bindi ...... with uterine serous carcinoma.
@nl
P2093
P1433
P1476
Overexpression of folate bindi ...... with uterine serous carcinoma.
@en
P2093
Andrew Berchuck
Carl Morrison
Chris Zahn
G Larry Maxwell
G Scott Rose
G V R Chandramouli
Jeff Fowler
John I Risinger
Louis A Dainty
Michael A Bidus
P304
P356
10.1016/J.YGYNO.2006.10.063
P407
P577
2007-04-02T00:00:00Z